Ruan, Y., Ruan, Y., Kim, H. N., Ogana, H. A., Wan, Z., Hurwitz, S., . . . Kim, Y. (2021). Preclinical Evaluation of a Novel Dual Targeting PI3Kδ/BRD4 Inhibitor, SF2535, in B-Cell Acute Lymphoblastic Leukemia. Frontiers Media S.A.
Chicago Style (17th ed.) CitationRuan, Yongsheng, et al. Preclinical Evaluation of a Novel Dual Targeting PI3Kδ/BRD4 Inhibitor, SF2535, in B-Cell Acute Lymphoblastic Leukemia. Frontiers Media S.A, 2021.
MLA (8th ed.) CitationRuan, Yongsheng, et al. Preclinical Evaluation of a Novel Dual Targeting PI3Kδ/BRD4 Inhibitor, SF2535, in B-Cell Acute Lymphoblastic Leukemia. Frontiers Media S.A, 2021.
Warning: These citations may not always be 100% accurate.